Cargando…

Mortality Among Adults With Cancer Undergoing Chemotherapy or Immunotherapy and Infected With COVID-19

IMPORTANCE: Large cohorts of patients with active cancers and COVID-19 infection are needed to provide evidence of the association of recent cancer treatment and cancer type with COVID-19 mortality. OBJECTIVE: To evaluate whether systemic anticancer treatments (SACTs), tumor subtypes, patient demogr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Várnai, Csilla, Palles, Claire, Arnold, Roland, Curley, Helen M., Purshouse, Karin, Cheng, Vinton W. T., Booth, Stephen, Campton, Naomi A., Collins, Graham P., Hughes, Daniel J., Kulasekararaj, Austin G., Lee, Alvin J. X., Olsson-Brown, Anna C., Sharma-Oates, Archana, Van Hemelrijck, Mieke, Lee, Lennard Y. W., Kerr, Rachel, Middleton, Gary, Cazier, Jean-Baptiste
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2022
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8861846/ https://www.ncbi.nlm.nih.gov/pubmed/35188551 http://dx.doi.org/10.1001/jamanetworkopen.2022.0130

Ejemplares similares

COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study
por: Lee, Lennard Y W, et al.
Publicado: (2020)

1703P UK Coronavirus Cancer Monitoring Project (UKCCMP): A national reporting network for real time data of the COVID-19 pandemic
por: Olsson-Brown, A.C., et al.
Publicado: (2020)

Key findings from the UKCCMP cohort of 877 patients with haematological malignancy and COVID‐19: disease control as an important factor relative to recent chemotherapy or anti‐CD20 therapy
por: Booth, Stephen, et al.
Publicado: (2021)

COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study
por: Lee, Lennard YW, et al.
Publicado: (2020)

Immune checkpoint blockade: releasing the breaks or a protective barrier to COVID-19 severe acute respiratory syndrome?
por: Pickles, Oliver J., et al.
Publicado: (2020)

COVID-19 in children with haematological malignancies
por: Millen, Gerard Cathal, et al.
Publicado: (2022)

Severity of COVID-19 in children with cancer: Report from the United Kingdom Paediatric Coronavirus Cancer Monitoring Project
por: Millen, Gerard C., et al.
Publicado: (2020)

Heterogeneity of germline variants in high risk breast and ovarian cancer susceptibility genes in India
por: Sharma-Oates, Archana, et al.
Publicado: (2018)

Corrigendum to: Heterogeneity of germline variants in high risk breast and ovarian cancer susceptibility genes in India
por: Sharma-Oates, Archana, et al.
Publicado: (2018)

1677MO COVID-19 mortality in hospitalized cancer patients is not significantly affected by chemotherapy or other anti-cancer treatments
por: Lee, L., et al.
Publicado: (2020)

COVID-19 and cancer registries: learning from the first peak of the SARS-CoV-2 pandemic
por: Lee, Alvin J. X., et al.
Publicado: (2021)

ToxNav germline genetic testing and PROMinet digital mobile application toxicity monitoring: Results of a prospective single‐center clinical utility study—PRECISE study
por: Lee, Lennard Y. W., et al.
Publicado: (2019)

Application of T‐cell receptor repertoire as a novel monitor in dynamic tracking and assessment: A cohort‐study based on RA patients
por: Yang, Peiqing, et al.
Publicado: (2022)

Tale of Two Fellows
por: Purshouse, Karin, et al.
Publicado: (2017)

Germline genetic variation and predicting immune checkpoint inhibitor induced toxicity
por: Chin, Ik Shin, et al.
Publicado: (2022)

Efficient Parameter Estimation of Generalizable Coarse-Grained Protein Force Fields Using Contrastive Divergence: A Maximum Likelihood Approach
por: Várnai, Csilla, et al.
Publicado: (2013)

Improving protein-protein interaction prediction using evolutionary information from low-quality MSAs
por: Várnai, Csilla, et al.
Publicado: (2017)

The Role of Real-World Evidence in UK Reimbursement: Case Study of Lenalidomide in Myelodysplastic Syndrome Deletion 5q
por: Lee, Dawn, et al.
Publicado: (2018)

Editorial: Bladder Cancer – A Cinderella Cancer: Advances and Remaining Research Questions
por: Van Hemelrijck, Mieke, et al.
Publicado: (2020)

Efficiently Differentiating Agonists and Competitive Antagonists for Weak Allosteric Protein–Ligand Interactions with Linear Response Theory
por: Davolio, Anthony J., et al.
Publicado: (2023)

Coronavirus Disease 2019: the Pivotal Role of UK Clinical Oncology and the UK Coronavirus Cancer Monitoring Project
por: Best, J., et al.
Publicado: (2021)

Comparison of Hi-C results using in-solution versus in-nucleus ligation
por: Nagano, Takashi, et al.
Publicado: (2015)

Your next clinical cancer research project: preparation in a multidisciplinary environment is key
por: Van Hemelrijck, Mieke, et al.
Publicado: (2017)

Expectant management in genitourinary malignancies (prostate, bladder, kidney)
por: Van Hemelrijck, Mieke, et al.
Publicado: (2021)

The need for research methodology to improve acceptability of long-term surveillance for cancer
por: Kinsella, Netty, et al.
Publicado: (2021)

A tribute to Fanconi: ‘clinical acumen still counts’
por: Kulasekararaj, Austin G., et al.
Publicado: (2022)

PARP Inhibitors in Prostate Cancer–the Preclinical Rationale and Current Clinical Development
por: Virtanen, Verneri, et al.
Publicado: (2019)

Robust hematopoietic specification requires the ubiquitous Sp1 and Sp3 transcription factors
por: Gilmour, Jane, et al.
Publicado: (2019)

GREVE: Genomic Recurrent Event ViEwer to assist the identification of patterns across individual cancer samples
por: Cazier, Jean-Baptiste, et al.
Publicado: (2012)

Is there any association between prostate-specific antigen screening frequency and uptake of active surveillance in men with low or very low risk prostate cancer?
por: Beckmann, Kerri, et al.
Publicado: (2019)

Ability of a biomarker-based score to predict death from circulatory disease and cancer in NHANES III
por: Van Hemelrijck, Mieke, et al.
Publicado: (2012)

Calcium Intake and Serum Concentration in Relation to Risk of Cardiovascular Death in NHANES III
por: Van Hemelrijck, Mieke, et al.
Publicado: (2013)

Research engagement among black men with prostate cancer
por: Toms, Charlotte, et al.
Publicado: (2016)

COVID-19 and treatment with NSAIDs and corticosteroids: should we be limiting their use in the clinical setting?
por: Russell, Beth, et al.
Publicado: (2020)

How does COVID‐19 impact treatment decision‐making for clinicians in localised kidney cancer
por: Beyer, Katharina, et al.
Publicado: (2020)

Editorial: The effects of COVID-19 on cancer research methods & strategies
por: Fox, Louis, et al.
Publicado: (2022)

Editorial: Immunologic Mechanisms of Myeloid Neoplasms
por: Fattizzo, Bruno, et al.
Publicado: (2022)

Biosimilars in rare diseases : a focus on paroxysmal nocturnal hemoglobinuria
por: Kulasekararaj, Austin, et al.
Publicado: (2022)

Pharmacogenomic biomarker information differences between drug labels in the United States and Hungary: implementation from medical practitioner view
por: Varnai, Reka, et al.
Publicado: (2019)

Differential clonal evolution in oesophageal cancers in response to neo-adjuvant chemotherapy
por: Findlay, John M., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_p3qjr5v5r7q61qpbga0e8kkrvo